Spots Global Cancer Trial Database for clinical observation
Every month we try and update this database with for clinical observation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate | NCT00084864 | Prostate Cancer | calcitriol dexamethasone clinical observ... | 18 Years - 120 Years | Roswell Park Cancer Institute | |
| Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery | NCT03180268 | Grade II Mening... Intracranial Me... | Clinical Observ... Radiation Thera... | 18 Years - | NRG Oncology | |
| Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer | NCT00058201 | Pancreatic Canc... | fluorouracil gemcitabine hyd... leucovorin calc... clinical observ... | 18 Years - | National Cancer Institute (NCI) | |
| Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery | NCT03180268 | Grade II Mening... Intracranial Me... | Clinical Observ... Radiation Thera... | 18 Years - | NRG Oncology | |
| Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial | NCT02275533 | Acute Myeloid L... | Biospecimen Col... Bone Marrow Bio... Clinical Observ... Echocardiograph... Nivolumab | 18 Years - | National Cancer Institute (NCI) | |
| Studying Changes in Breast Density in Patients With Early-Stage Breast Cancer Treated With Metformin Hydrochloride or Placebo on CAN-NCIC-MA.32 | NCT01666171 | Breast Cancer | metformin hydro... clinical observ... diagnostic labo... imaging biomark... medical chart r... digital mammogr... | 18 Years - 74 Years | National Cancer Institute (NCI) | |
| Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma | NCT00033293 | Localized Resec... Localized Unres... Regional Neurob... Stage 4 Neurobl... Stage 4S Neurob... | Clinical Observ... Cyclophosphamid... Laboratory Biom... Magnetic Resona... Prednisone Therapeutic Imm... | - 8 Years | Children's Oncology Group | |
| Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission | NCT00093470 | Acute Myeloid L... Adult Acute Meg... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Alkylating Agen... Myelodysplastic... Recurrent Adult... | Clinical Observ... Tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial | NCT02275533 | Acute Myeloid L... | Biospecimen Col... Bone Marrow Bio... Clinical Observ... Echocardiograph... Nivolumab | 18 Years - | National Cancer Institute (NCI) | |
| Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma | NCT01169337 | Light Chain Dep... Smoldering Mult... | Clinical Observ... Lenalidomide Quality-of-Life... | 18 Years - | National Cancer Institute (NCI) | |
| Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) | NCT02201992 | ALK Gene Rearra... ALK Gene Transl... ALK Positive Stage IB Non-Sm... Stage II Non-Sm... Stage IIA Non-S... Stage IIB Non-S... Stage IIIA Non-... | Clinical Observ... Crizotinib Laboratory Biom... | 18 Years - | Eastern Cooperative Oncology Group | |
| Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) | NCT02194738 | Stage IB Lung N... Stage II Lung N... Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... Stage IIIA Lung... Stage IIIB Lung... | Biospecimen Col... Carboplatin Cisplatin Clinical Observ... Computed Tomogr... Crizotinib Cytology Specim... Echocardiograph... Erlotinib Gemcitabine Hyd... Nivolumab Paclitaxel Pembrolizumab Pemetrexed Pemetrexed Diso... Placebo Adminis... Positron Emissi... | 18 Years - | National Cancer Institute (NCI) | |
| Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery Only | NCT00416559 | Long-term Effec... Neuroblastoma | clinical observ... | - 20 Years | National Cancer Institute (NCI) | |
| Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA | NCT02135042 | Epstein-Barr Vi... Stage II Nasoph... Stage III Nasop... Stage IVA Nasop... Stage IVB Nasop... | Cisplatin Clinical Observ... Fluorouracil Gemcitabine Hyd... Intensity-Modul... Laboratory Biom... Paclitaxel Quality-of-Life... | 18 Years - | NRG Oncology | |
| Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer | NCT00363584 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | capecitabine clinical observ... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer | NCT00002651 | Prostate Cancer | bicalutamide goserelin aceta... clinical observ... | 18 Years - | SWOG Cancer Research Network | |
| Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer | NCT00108745 | Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Ovarian Brenner... Ovarian Clear C... Ovarian Endomet... Ovarian Mucinou... Ovarian Seromuc... Ovarian Serous ... Ovarian Transit... Ovarian Undiffe... Primary Periton... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... | Clinical Observ... Laboratory Biom... Paclitaxel Paclitaxel Poli... Quality-of-Life... | - | GOG Foundation | |
| Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery Only | NCT00416559 | Long-term Effec... Neuroblastoma | clinical observ... | - 20 Years | National Cancer Institute (NCI) | |
| Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer | NCT06200103 | Castration-Resi... Stage IVB Prost... | Biospecimen Col... Bone Scan Clinical Observ... Computed Tomogr... Gallium Ga 68 G... Lutetium Lu 177... Positron Emissi... Questionnaire A... Single Photon E... | 18 Years - | Mayo Clinic | |
| Radiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by Surgery | NCT00410683 | Non-small Cell ... | clinical observ... adjuvant therap... 3-dimensional c... | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery | NCT03180268 | Grade II Mening... Intracranial Me... | Clinical Observ... Radiation Thera... | 18 Years - | NRG Oncology | |
| Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia | NCT00006363 | Adult Acute Bas... Adult Acute Eos... Adult Acute Ery... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Myelo... de Novo Myelody... Untreated Adult... Untreated Child... | cytarabine daunorubicin hy... etoposide valspodar filgrastim busulfan autologous hema... peripheral bloo... aldesleukin clinical observ... pharmacological... | 15 Years - 59 Years | National Cancer Institute (NCI) | |
| Radiation Therapy and Rituximab in Treating Patients With Stage I-II Grade 1 or Grade 2 Follicular Lymphoma | NCT01473628 | Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... | Clinical Observ... Radiation Thera... Rituximab | 18 Years - | M.D. Anderson Cancer Center | |
| Observation in Patients With Early-Stage Vulvar Cancer Undergoing Sentinel Lymph Node Dissection | NCT01500512 | Stage I Vulvar ... Stage II Vulvar... Stage III Vulva... Vulvar Squamous... | Clinical Observ... | 18 Years - | GOG Foundation | |
| Perceptions of Side Effects of Cancer Chemoradiotherapy | NCT02978846 | Malignant Neopl... Side Effect | Clinical Observ... | 18 Years - | University of Southern California | |
| Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer | NCT00363584 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | capecitabine clinical observ... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer | NCT00776100 | Lung Cancer | clinical observ... radiation thera... | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer | NCT00058201 | Pancreatic Canc... | fluorouracil gemcitabine hyd... leucovorin calc... clinical observ... | 18 Years - | National Cancer Institute (NCI) | |
| Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) | NCT02194738 | Stage IB Lung N... Stage II Lung N... Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... Stage IIIA Lung... Stage IIIB Lung... | Biospecimen Col... Carboplatin Cisplatin Clinical Observ... Computed Tomogr... Crizotinib Cytology Specim... Echocardiograph... Erlotinib Gemcitabine Hyd... Nivolumab Paclitaxel Pembrolizumab Pemetrexed Pemetrexed Diso... Placebo Adminis... Positron Emissi... | 18 Years - | National Cancer Institute (NCI) | |
| Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia | NCT01164722 | Anal Cancer Neoplasm of Unc... Nonneoplastic C... Precancerous Co... | clinical observ... infrared photoc... | 27 Years - | AIDS Malignancy Consortium | |
| Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer | NCT01251861 | Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... | Akt Inhibitor M... Bicalutamide Clinical Observ... Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) | NCT02193282 | Lung Non-Squamo... Stage IB Lung N... Stage II Lung N... Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... | Clinical Observ... Erlotinib Hydro... Laboratory Biom... Placebo Adminis... | 18 Years - | National Cancer Institute (NCI) | |
| Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer | NCT01725165 | Recurrent Lung ... Stage IV Non-Sm... | Clinical Observ... External Beam R... Laboratory Biom... Quality-of-Life... Standard Follow... Therapeutic Con... | 18 Years - | M.D. Anderson Cancer Center | |
| Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission | NCT00093470 | Acute Myeloid L... Adult Acute Meg... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Alkylating Agen... Myelodysplastic... Recurrent Adult... | Clinical Observ... Tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery | NCT01313377 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | gemcitabine hyd... oxaliplatin clinical observ... adjuvant therap... quality-of-life... | 18 Years - 120 Years | UNICANCER | |
| Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia | NCT01164722 | Anal Cancer Neoplasm of Unc... Nonneoplastic C... Precancerous Co... | clinical observ... infrared photoc... | 27 Years - | AIDS Malignancy Consortium | |
| Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy | NCT01200602 | Anorexia Weight Changes | megestrol aceta... clinical observ... | - 21 Years | Mayo Clinic | |
| Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) | NCT02201992 | ALK Gene Rearra... ALK Gene Transl... ALK Positive Stage IB Non-Sm... Stage II Non-Sm... Stage IIA Non-S... Stage IIB Non-S... Stage IIIA Non-... | Clinical Observ... Crizotinib Laboratory Biom... | 18 Years - | Eastern Cooperative Oncology Group | |
| Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma | NCT01096368 | Anaplastic Epen... Brain Ependymom... Cellular Ependy... Clear Cell Epen... Ependymoma Papillary Epend... | 3-Dimensional C... Carboplatin Cisplatin Clinical Observ... Cyclophosphamid... Etoposide Filgrastim Laboratory Biom... Mesna Vincristine | 12 Months - 21 Years | Children's Oncology Group | |
| Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia | NCT00006363 | Adult Acute Bas... Adult Acute Eos... Adult Acute Ery... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Myelo... de Novo Myelody... Untreated Adult... Untreated Child... | cytarabine daunorubicin hy... etoposide valspodar filgrastim busulfan autologous hema... peripheral bloo... aldesleukin clinical observ... pharmacological... | 15 Years - 59 Years | National Cancer Institute (NCI) | |
| Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma | NCT02176967 | Ganglioneurobla... Localized Resec... Localized Unres... Neuroblastoma | Biopsy Bone Marrow Asp... Bone Marrow Bio... Carboplatin Clinical Observ... Computed Tomogr... Cyclophosphamid... Doxorubicin Hyd... Etoposide Magnetic Resona... Ultrasound | - 18 Months | Children's Oncology Group | |
| Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery | NCT01313377 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | gemcitabine hyd... oxaliplatin clinical observ... adjuvant therap... quality-of-life... | 18 Years - 120 Years | UNICANCER | |
| Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia | NCT01164722 | Anal Cancer Neoplasm of Unc... Nonneoplastic C... Precancerous Co... | clinical observ... infrared photoc... | 27 Years - | AIDS Malignancy Consortium | |
| Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy | NCT01085630 | Malignant Mesot... | pemetrexed diso... clinical observ... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery | NCT01533207 | Stage I Uterine... Uterine Corpus ... | Clinical Observ... Docetaxel Doxorubicin Hyd... Filgrastim Gemcitabine Hyd... Pegfilgrastim | 18 Years - | GOG Foundation | |
| Radiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by Surgery | NCT00410683 | Non-small Cell ... | clinical observ... adjuvant therap... 3-dimensional c... | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma | NCT01096368 | Anaplastic Epen... Brain Ependymom... Cellular Ependy... Clear Cell Epen... Ependymoma Papillary Epend... | 3-Dimensional C... Carboplatin Cisplatin Clinical Observ... Cyclophosphamid... Etoposide Filgrastim Laboratory Biom... Mesna Vincristine | 12 Months - 21 Years | Children's Oncology Group | |
| Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer | NCT06388018 | Stage I Uterine... Stage II Uterin... Stage III Uteri... | Clinical Observ... Computed Tomogr... External Beam R... High-Dose-Rate ... Magnetic Resona... Positron Emissi... Questionnaire A... X-Ray Imaging | 18 Years - | NRG Oncology | |
| Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) | NCT02194738 | Stage IB Lung N... Stage II Lung N... Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... Stage IIIA Lung... Stage IIIB Lung... | Biospecimen Col... Carboplatin Cisplatin Clinical Observ... Computed Tomogr... Crizotinib Cytology Specim... Echocardiograph... Erlotinib Gemcitabine Hyd... Nivolumab Paclitaxel Pembrolizumab Pemetrexed Pemetrexed Diso... Placebo Adminis... Positron Emissi... | 18 Years - | National Cancer Institute (NCI) | |
| Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer | NCT00058201 | Pancreatic Canc... | fluorouracil gemcitabine hyd... leucovorin calc... clinical observ... | 18 Years - | National Cancer Institute (NCI) | |
| Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma | NCT02176967 | Ganglioneurobla... Localized Resec... Localized Unres... Neuroblastoma | Biopsy Bone Marrow Asp... Bone Marrow Bio... Carboplatin Clinical Observ... Computed Tomogr... Cyclophosphamid... Doxorubicin Hyd... Etoposide Magnetic Resona... Ultrasound | - 18 Months | Children's Oncology Group | |
| Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme | NCT01122888 | Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Solid Neo... Recurrent Adult... | Cilengitide Clinical Observ... Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated on Clinical Trial CAN-NCIC-LY9 | NCT00400907 | Long-term Effec... Lymphoma | clinical observ... management of t... | 18 Years - 60 Years | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
